“APAC faces a disproportionate burden of vision impairment”

What are the major plans in store at HOYA Vision Care for 2025, for the Asia market? Asia remains a key market for HOYA...

May 31, 2025 | Saturday | Opinion
Upskilling and flexibility are key to staying relevant as hiring grows

The biopharma job market has been tough, with widespread downsizing and frequent layoffs across big pharma. But the wors...

May 31, 2025 | Saturday | Analysis
APAC's Alliance-Driven Biotech Boom

Biotech partnerships of APAC differ in a variety of ways from most global collaborations, primarily due to the unique ge...

May 31, 2025 | Saturday | News
Australia approves new therapy for children with growth hormone deficiency

Singapore-based biopharmaceutical company Specialised Therapeutics (ST) has announced the Australian registration of SKY...

May 30, 2025 | Friday | News
Nuclera and Cytiva team up to accelerate characterisation of proteins for drug development

Nuclera, a UK-based biotechnology company accelerating protein expression and optimisation through its benchtop eProtein...

May 30, 2025 | Friday | News
Japan establishes first next-gen commercial production site for CAR-T cell therapies

Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui Fudosan, has announced the est...

May 30, 2025 | Friday | News
Australia's IonOpticks Generation 4 Aurora Series sets new benchmark in chromatography

Australia-based IonOpticks, developer of chromatography columns for mass spectrometry research, has announced the l...

May 29, 2025 | Thursday | News
Taiwan's Formosa Pharma inks deal with Adalvo for treatment of ocular inflammation and pain

Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Adalvo Limited in the Europe...

May 29, 2025 | Thursday | News
AVING News interacts with Dr Manbeena Chawla, Executive Editor, BioSpectrum Asia at ICPI Week 2025

  ICPI Week 2025 Wrap-Up ICPI WEEK 2025 WRAP-UP | BY MANBEENA CHAWLA, EXECUTIVE EDITOR, BIOSPECTRUM ASIA ...

May 23, 2025 | Friday | Opinion
Lilly's Kisunla receives marketing authorisation in Australia for treatment of early symptomatic Alzheimer's disease

Eli Lilly and Company has announced that the Australian Therapeutic Goods Administration (TGA) has granted marketing aut...

May 23, 2025 | Friday | News
Medtronic announces intent to separate diabetes business

Ireland-headquartered Medtronic plc, a global leader in healthcare technology, has announced its intent to separate its ...

May 22, 2025 | Thursday | News
Australia's Kailo Medical acquires REI AI to transform future of radiology reporting

Australia-based Kailo Medical, a global leader in structured reporting for medical imaging, has announced its acquisitio...

May 22, 2025 | Thursday | News
Pfizer enters into exclusive licensing agreement worth $4.8 B with China's 3SBio

Pfizer Inc. has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc., a leading Chinese biop...

May 20, 2025 | Tuesday | News
Japanese startup RevolKa secures $1.4 M funding to advance therapeutic programmes

RevolKa Ltd., a venture-backed biotech company providing a cutting-edge artificial intelligence (AI)-driven protein engi...

May 20, 2025 | Tuesday | News
Gene Solutions and NEWCL forge strategic partnership to advance genetic testing in Taiwan

In a groundbreaking move, Gene Solutions, a leader in prenatal and oncology genetic testing, and NEWCL Biomedical Labora...

May 16, 2025 | Friday | News
China's Viva Biotech launches new AI-driven drug discovery platform

China-based Viva Biotech recently held the AIDD platform launch event "Enchantment of Drug Discovery," unveiling the adv...

May 16, 2025 | Friday | News
Korean startup Rznomics partners with Eli Lilly to commercialise RNA-editing therapeutics

Rznomics Inc., a South Korea-based biopharmaceutical startup specialising in RNA-based therapeutics, has entered in...

May 16, 2025 | Friday | News
Targeting inflammation at the source: VX-01 aims to redefine NPDR treatment with first oral therapy

Patients with non-proliferative diabetic retinopathy (NPDR) currently face a therapeutic gap—one that often leaves...

May 16, 2025 | Friday | News